JACKSON CENTER, PA / ACCESSWIRE / September 27, 2022 / Halberd Corporation (OTC PINK:HALB) entered into a strategic alliance with AI Longevity, Inc. and Stem of Hope to form a strategic alliance as a ...
Halberd demonstrated elimination of the final two of the "Top Ten" antigens linked to neurodegenerative diseases. Halberd demonstrated that its antigen elimination process is able to selectively ...
Hosted on MSN
Halberd axe makeover with epoxy
In this video, I restore a Halberd Axe over a span of 15 days, utilizing a $2 axe and $25 worth of epoxy resin. #Halberd #Axe #Restoration Is blue dot fever the cause of tour cancellations? Bella ...
Mississippi State University (MSU) is well on their way in testing Halberd's patent-pending nasal spray to mitigate the neurological effects resulting from traumatic brain injuries (TBI). By directly ...
A Major Step Towards the Elimination of Multiple Infectious Diseases and Possible Treatment for Alzheimer's Disease/PTSD/CTE Felder continued, "Our method envisions utilizing a dialysis variation in ...
JACKSON CENTER, PA / ACCESSWIRE / January 25, 2021 / Halberd Corp. (OTC PINK:HALB) research produces qualitative and quantitative diagnostic methodology to detect the presence of the SARS-COV-2 ...
JACKSON CENTER, PA / ACCESSWIRE / April 30, 2024 / Halberd Corporation (OTC PINK:HALB) announced a pre-pilot study of its patented LDN+ drug with military volunteers has now begun with limited ...
Halberd management has guided the company thus far to achieve technological advancements beyond those of Big Pharma. Halberd's success was demonstrated by way of publication of the peer-reviewed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results